Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
5
42%
Ph phase_3
5
42%
Ph phase_2
2
17%

Phase Distribution

5

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
5(41.7%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
5(41.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(12)

Detailed Status

Completed12

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (41.7%)
Phase 22 (16.7%)
Phase 35 (41.7%)

Trials by Status

completed12100%

Recent Activity

0 active trials
Showing 5 of 12
completedphase_2

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

NCT02753894
completedphase_1

A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules

NCT02531204
completedphase_3

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742611
completedphase_3

A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

NCT01017276
completedphase_3

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

NCT00892749
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT02753894Phase 2

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Completed
NCT02531204Phase 1

A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 Capsules

Completed
NCT01742611Phase 3

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Completed
NCT01017276Phase 3

A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

Completed
NCT00892749Phase 3

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Completed
NCT01057407Phase 3

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Completed
NCT01742585Phase 3

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Completed
NCT01124747Phase 1

A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug

Completed
NCT00505037Phase 2

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Completed
NCT01115946Phase 1

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy Volunteers

Completed
NCT01115972Phase 1

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers

Completed
NCT01115985Phase 1

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12